Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Recruiting in Palo Alto (17 mi)

+7 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Potrero Medical

No Placebo Group

Trial Summary

What is the purpose of this trial?

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Eligibility Criteria

Inclusion Criteria

Signed or Verbal Informed Consent as required by IRB (if applicable).

Adult (age ≥ 18).

Monitored on the Accuryn® Monitoring System during their procedure and ICU stay (for retrospective enrollment).

See 1 more

Treatment Details

Interventions

Accuryn Monitoring System (Device)

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Accuryn Monitoring SystemExperimental Treatment1 Intervention

Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay